Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The science at HIVR4P 2024: The era of choice in biomedical HIV prevention.
Grinsztejn B, Appay V, Bekker LG, Beyrer C, Donnell D, Sanchez J, Canagasabey D, Coutinho C, Ganor Y, Muturi-Kioi V, Ortblad KF, Cooney E, Devisich G, Ellenberg P, Ghiglione Y, K'Orimba K, Ssemambo PK, Ludwig-Barron NT, Mielke DK, Mullick R, Muthui MK, Radusky PD, Sendaula E, Tirmizi SRH, Sanchez AVM, Vega J, Pebody R. Grinsztejn B, et al. Among authors: appay v. J Int AIDS Soc. 2025 Jul;28(7):e70001. doi: 10.1002/jia2.70001. J Int AIDS Soc. 2025. PMID: 40598755
Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19.
Autaa G, Papagno L, Nogimori T, Boizard-Moracchini A, Korenkov D, Roy M, Suzuki K, Masuta Y, White E, Llewellyn-Lacey S, Yoshioka Y, Nicoli F, Price DA, Dechanet-Merville J, Yamamoto T, Pellegrin I, Appay V. Autaa G, et al. Among authors: appay v. JCI Insight. 2025 Jan 23;10(4):e180867. doi: 10.1172/jci.insight.180867. JCI Insight. 2025. PMID: 39847442 Free PMC article.
Clonal succession after prolonged antiretroviral therapy rejuvenates CD8+ T cell responses against HIV-1.
White E, Papagno L, Samri A, Sugata K, Hejblum B, Henry AR, Rogan DC, Darko S, Recordon-Pinson P, Dudoit Y, Llewellyn-Lacey S, Chakrabarti LA, Buseyne F, Migueles SA, Price DA, Andreola MA, Satou Y, Thiebaut R, Katlama C, Autran B, Douek DC, Appay V. White E, et al. Among authors: appay v. Nat Immunol. 2024 Sep;25(9):1555-1564. doi: 10.1038/s41590-024-01931-9. Epub 2024 Aug 23. Nat Immunol. 2024. PMID: 39179934 Free article.
Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination.
Benhamouda N, Besbes A, Bauer R, Mabrouk N, Gadouas G, Desaint C, Chevrier L, Lefebvre M, Radenne A, Roelens M, Parfait B, Weiskopf D, Sette A, Gruel N, Courbebaisse M, Appay V, Paul S, Gorochov G, Ropers J, Lebbah S, Lelievre JD, Johannes L, Ulmer J, Lebeaux D, Friedlander G, De Lamballerie X, Ravel P, Kieny MP, Batteux F, Durier C, Launay O, Tartour E. Benhamouda N, et al. Among authors: appay v. iScience. 2024 Jul 2;27(8):110441. doi: 10.1016/j.isci.2024.110441. eCollection 2024 Aug 16. iScience. 2024. PMID: 39104410 Free PMC article.
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19.
Dallan B, Proietto D, De Laurentis M, Gallerani E, Martino M, Ghisellini S, Zurlo A, Volpato S, Govoni B, Borghesi M, Albanese V, Appay V, Bonnini S, Llewellyn-Lacey S, Pacifico S, Grumiro L, Brandolini M, Semprini S, Sambri V, Ladell K, Parry HM, Moss PAH, Price DA; RIV Study Group; Caputo A, Gavioli R, Nicoli F. Dallan B, et al. Among authors: appay v. Nat Aging. 2024 Aug;4(8):1121-1136. doi: 10.1038/s43587-024-00644-w. Epub 2024 Jun 25. Nat Aging. 2024. PMID: 38918602
Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection.
Bachelard A, Le Hingrat Q, Ferré VM, Lê M, Peytavin G, Damond F, Charpentier C, Fremont Goudot G, Goupil de Bouille J, Lariven S, Delobel P, Yazdanpanah Y, Descamps D, Matheron S, Ghosn J; ANRS CO05 VIH-2 cohort study group. Bachelard A, et al. Clin Infect Dis. 2024 Apr 10;78(4):1005-1010. doi: 10.1093/cid/ciad695. Clin Infect Dis. 2024. PMID: 38630945
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Hentzien M, Bonnet F, Bernasconi E, Biver E, Braun DL, Munting A, Leuzinger K, Leleux O, Musardo S, Prendki V, Schmid P, Staehelin C, Stoeckle M, Walti CS, Wittkop L, Appay V, Didierlaurent AM, Calmy A. Hentzien M, et al. Among authors: appay v. BMC Infect Dis. 2024 Mar 19;24(1):329. doi: 10.1186/s12879-024-09192-5. BMC Infect Dis. 2024. PMID: 38504173 Free PMC article.
CD8 + T-cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapy.
Cabral-Piccin MP, Briceño O, Papagno L, Liouville B, White E, Perdomo-Celis F, Autaa G, Volant S, Llewellyn-Lacey S, Fromentin R, Chomont N, Price DA, Sáez-Cirión A, Lambotte O, Katlama C, Appay V. Cabral-Piccin MP, et al. Among authors: appay v. AIDS. 2024 Feb 1;38(2):161-166. doi: 10.1097/QAD.0000000000003746. Epub 2023 Oct 5. AIDS. 2024. PMID: 37800637
131 results